Syndax Pharmaceuticals Inc
F:1T3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Syndax Pharmaceuticals Inc
F:1T3
|
US |
|
F
|
First Industrial Realty Trust Inc
F:F5W
|
US |
|
Mapfre SA
OTC:MPFRF
|
ES |
|
Berkshire Hathaway Inc
BMV:BRKB
|
US |
|
B
|
Berkshire Hathaway Inc
XHAM:BRYN
|
US |
|
Northern Graphite Corp
F:0NG
|
CA |
|
Uni-President China Holdings Ltd
F:58U
|
CN |
|
T
|
Tandem Diabetes Care Inc
F:TD5A
|
US |
|
Television Francaise 1 SA
F:FSE
|
FR |
|
Chiyoda Corp
TSE:6366
|
JP |
|
S
|
Sodexo SA
XMUN:SJ7
|
FR |
|
Jumbo SA
F:5JB1
|
GR |
|
S
|
Shanghai Haohai Biological Technology Co Ltd
F:5HB
|
CN |
|
E
|
Elbit Systems Ltd
SWB:EB2
|
IL |
|
A
|
AT&T Inc
F:SOBA
|
US |
|
M
|
Metcash Ltd
F:MG9
|
AU |
|
Petroleo Brasileiro SA Petrobras
BOVESPA:PETR4
|
BR |
|
A
|
ADVERO Properties Socimi SA
MAD:YADV
|
ES |
|
BlackRock TCP Capital Corp
NASDAQ:TCPC
|
US |
|
F
|
Fosun International Ltd
OTC:FOSUF
|
HK |
|
Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP
F:SAJA
|
BR |
|
Kelt Exploration Ltd
F:2KE
|
CA |
|
A
|
Aker Solutions ASA
F:1AKA
|
NO |
|
ITC Ltd
NSE:ITC
|
IN |
Bankruptcy Probability
Syndax Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Syndax Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
|
1.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Syndax Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Syndax Pharmaceuticals Inc has total debt of 588.1m USD. This includes both short-term (0 USD) and long-term (588.1m USD) debt.
You can find a full breakdown on its Balance Sheet.